The topic of this article may not meet Wikipedia's notability guidelines for products and services. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Cypher stent" – news · newspapers · books · scholar · JSTOR(March 2024) (Learn how and when to remove this message)
Cypher is a brand of drug-eluting coronary stent from Cordis Corporation, a Cardinal Health company. During a balloon angioplasty, the stent is inserted into the artery to provide a "scaffold" to open the artery. An anti-rejection-type medication, sirolimus, helps to limit the overgrowth of normal cells while the artery heals which reduces the chance of re-blockage in the treated area known as restenosis, and reduces the chances that another procedure is required.[1][2]
The Cypher stent was approved for use by the FDA in 2003.[2] Following claims of inconsistent manufacturing processes and poor sales, Johnson & Johnson have announced that it will stop selling Cypher stents by the end of 2011.[3]
^"Learn about CYPHER Stent, the latest advance in stent technology". Cordis Corporation. Archived from the original on 2004-06-26. Retrieved 2008-04-01.
^ ab"CYPHER™ Sirolimus-eluting Coronary Stent - P020026". FDA.gov. U.S. Food and Drug Administration. Retrieved 1 Aug 2016.
Cypher is a brand of drug-eluting coronary stent from Cordis Corporation, a Cardinal Health company. During a balloon angioplasty, the stent is inserted...
released in 2012 Cypherstent, a type of drug-eluting stentCypher Query Language, a declarative query language for graph databases Royal cypher Monogram Cipher...
cell replication. As with the Cypherstent before it, the first trials of the Taxus stent revealed no evidence of in-stent restenosis at six months after...
Cordis, a division of Johnson & Johnson, under the tradename Cypher. However, this kind of stent may also increase the risk of vascular thrombosis. Sirolimus...
the first to use Impella heart support device and Drug-eluting stents, Bioresorbable stents and thrombectomy devices in India. He is known to have contributed...
attack", and "TYPHOON: Trial to assess the use of the cYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty"...
European Medicines Agency. Retrieved 25 September 2012. "CYPHER Sirolimus-eluting Coronary Stent - P020026". Food and Drug Administration. Retrieved 25...
was more affined to traditional Far Eastern philosophy," according to Stent. ...The young Bohr thus lived in two worlds, but mostly the cultural Christianity...
Officer Thomas William Prior, C/J.114764. Chief Petty Officer Victor Tom Stent, D/J.32738. Chief Petty Officer Thomas George Tallyn, P/J41461. Chief Yeoman...
Global Information